Factors associated with phosphodiesterase type 5 inhibitor treatment satisfactions: results of patient interrogation

Cimen S., Demir O., ASLAN G., ESEN A. A.

AGING MALE, cilt.12, ss.58-61, 2009 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 12
  • Basım Tarihi: 2009
  • Doi Numarası: 10.1080/13685530903033232
  • Dergi Adı: AGING MALE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.58-61
  • Anahtar Kelimeler: Discontinuation, drop-out, erectile dysfunction, patient interrogation, PDE5 inhibitor, treatment, MALE ERECTILE DYSFUNCTION, SILDENAFIL, UPDATE, EPIDEMIOLOGY
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Introduction. Phosphodiesterase type 5 (PDE5) inhibitor therapy is an efficacious means of treatment for erectile dysfunction (ED). PDE5 inhibitors supply penile erection by inhibiting the hydrolysis of cGMP and therefore relaxing the corpus cavernosum. In this study, retrospective evaluation of those patients who were admitted to our clinic with the complaint of ED and who were recommended on PDE5 inhibitor treatment in terms of follow-up results and patient satisfaction were aimed.